Unknown

Dataset Information

Lipid metabolic pathways as lung cancer therapeutic targets: a computational study.


ABSTRACT: Inhibitors of lipid metabolic pathways, particularly drugs targeting the mevalonate pathway, have been suggested to be valuable in enhancing the effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and these compounds may also be effective in patients with inherent or acquired resistance to EGFR-TKIs. The present study examined gene expression profiles in lung adenocarcinoma to characterize the interaction between growth factor signals and lipid metabolic pathways at the transcriptional level. Gene expression correlation analysis showed that genes involved in the mevalonate pathway and unsaturated fatty acid synthesis were negatively correlated with the expression of EGFR, MET and other growth factor receptor genes, as well as with the expression of gene

SUBMITTER: Yano K 

PROVIDER: S-EPMC3573709 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature